{
  "ticker": "ELVN",
  "success": true,
  "price": {
    "current": 25.67,
    "currency": "USD",
    "day_high": 25.75,
    "day_low": 24.895,
    "52_week_high": 29.98,
    "52_week_low": 13.3
  },
  "market_cap": {
    "value": 1523445632.0,
    "currency": "USD"
  },
  "shares_outstanding": 59347317.0,
  "volume": {
    "last": 1095130,
    "average_30d": 1505092
  },
  "valuation": {
    "pe_ratio": null,
    "forward_pe": -10.831224,
    "price_to_book": 3.1951704
  },
  "company_info": {
    "name": "Enliven Therapeutics, Inc.",
    "sector": "Healthcare",
    "industry": "Biotechnology"
  },
  "balance_sheet": {
    "success": true,
    "period_date": "2025-09-30",
    "total_assets": 490875000.0,
    "total_liabilities": 14753000.0,
    "stockholders_equity": 476122000.0,
    "cash": 101732000.0,
    "marketable_securities": 375833000.0,
    "total_liquidity": 477565000.0,
    "total_debt": 387000.0,
    "long_term_debt": null,
    "current_debt": 387000.0,
    "error": null
  },
  "data_quality": {
    "flags": [],
    "has_price": true,
    "has_market_cap": true,
    "has_volume": true,
    "has_balance_sheet": true
  },
  "provenance": {
    "source": "Yahoo Finance via yfinance",
    "timestamp": "2026-01-29T16:31:30.308415",
    "url": "https://finance.yahoo.com/quote/ELVN",
    "data_hash": "04488eb623f42fe4"
  }
}